Medical University of Vienna-ko ikertzaileekin lankidetzan egindako argitalpenak (19)

2024

  1. Characterization and Management of Stable Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Implantation

    Journal of Clinical Medicine, Vol. 13, Núm. 12

  2. Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 42, Núm. 14, pp. 1612-1618

  3. Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial

    The Lancet, Vol. 403, Núm. 10444, pp. 2597-2605

  4. TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and multivessel or advanced coronary disease: The transcatheter valve and vessels trial (TCW trial): Design and rationale

    American Heart Journal, Vol. 270, pp. 86-94

2023

  1. Safety and Efficacy of ApTOLL in Patients with Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial

    JAMA Neurology, Vol. 80, Núm. 8, pp. 779-788

2022

  1. 6-Month Outcomes of the TricValve System in Patients With Tricuspid Regurgitation: The TRICUS EURO Study

    JACC: Cardiovascular Interventions, Vol. 15, Núm. 13, pp. 1366-1377

  2. Clinical outcomes of transcatheter aortic valve implantation in patients younger than 70 years rejected for surgery: the AMTRAC registry

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 17, Núm. 16, pp. 1289-1297

  3. Early Clinical Experience With the TRICENTO Bicaval Valved Stent for Treatment of Symptomatic Severe Tricuspid Regurgitation: A Multicenter Registry

    Circulation. Cardiovascular interventions, Vol. 15, Núm. 3, pp. e011302

  4. Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODA

    Nephrology Dialysis Transplantation, Vol. 37, Núm. 6, pp. 1140-1151

  5. Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 40, Núm. 3, pp. 242-251

  6. Sex differences in COVID-19 mortality risk in patients on kidney function replacement therapy

    Scientific Reports, Vol. 12, Núm. 1

  7. Transapical mitral valve implantation for treatment of symptomatic mitral valve disease: a real-world multicentre experience

    European Journal of Heart Failure, Vol. 24, Núm. 5, pp. 899-907

2021

  1. COVID-19-related mortality in kidney transplant and haemodialysis patients: A comparative, prospective registry-based study

    Nephrology Dialysis Transplantation, Vol. 36, Núm. 11, pp. 2094-2105

  2. Clinical triage of patients on kidney replacement therapy presenting with COVID-19: An ERACODA registry analysis

    Nephrology Dialysis Transplantation, Vol. 36, Núm. 12, pp. 2308-2320

  3. Effect of Transcatheter Aortic Valve Replacement on Concomitant Mitral Regurgitation and Its Impact on Mortality

    JACC: Cardiovascular Interventions, Vol. 14, Núm. 11, pp. 1181-1192

  4. Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease

    Neurology, Vol. 97, Núm. 14, pp. E1367-E1381

2020

  1. COVID-19-related mortality in kidney transplant and dialysis patients: Results of the ERACODA collaboration

    Nephrology Dialysis Transplantation, Vol. 35, Núm. 11, pp. 1973-1983

  2. Transcatheter Treatment of Residual Significant Mitral Regurgitation Following TAVR: A Multicenter Registry

    JACC: Cardiovascular Interventions, Vol. 13, Núm. 23, pp. 2782-2791

2017

  1. Clinical manifestations of the anti-IgLON5 disease

    Neurology, Vol. 88, Núm. 18, pp. 1736-1743